CCRM’s Board of Directors represents extensive experience in company creation, international academic excellence, and seasoned leaders.
Chair
- Michael Nobrega, IBI Group, Canada
Board
- Emmanuel Abate, Cytiva, France
- Dozie Amuzie, Johnson & Johnson Innovation-JLABS, Canada
- Reni Benjamin, JMP Securities, LLC, USA
- Abi Coman-Walker, Acuitas Therapeutics, Canada
- Michael May, CCRM, Canada
- Christopher Paige, University Health Network, Canada
- Leah Cowen, University of Toronto, Canada
- Joan Sheehan, STEMCELL Technologies Inc., Canada
- Peter Zandstra, CCRM and University of British Columbia, Canada
- Claudia Zylberberg, Akron Biotechnology, USA
Past Board Members
Thank you to those who have contributed their valuable time, insights, and expertise to CCRM’s Board of Directors during their committed terms.
- Lalit Aggarwal, Manor Park Holdings, Canada
- Gregory A. Bonfiglio, Inaugural Chair, Proteus Venture Partners, USA
- Allen Eaves, STEMCELL Technologies Inc., Canada
- Dianne Carmichael, McKesson, Canada
- Melissa Carpenter, Carpenter Group, Stem Cell Strategies, USA
- Catarina Flyborg, Cytiva, Sweden
- Vivek Goel, University of Toronto, Canada
- Rafi Hofstein, MaRS Innovation, Canada
- Sven Kili, Antion Biosciences, Switzerland
- Peter Lewis, University of Toronto, Canada
- Geoff MacKay, AVROBIO, USA
- Ruth McKernan, Pfizer Regenerative Medicine, USA and UK
- Stephen Minger, SLM Blue Skies Innovations, UK
- Gail Naughton, Histogen Inc., USA
- Lita Nelsen, Massachusetts Institute of Technology, USA
- Edward (Ted) Sargent, University of Toronto, Canada
- David Smith, Healios, Japan
- Susan L. Solomon, New York Stem Cell Foundation (NYSCF), USA
- Duncan Stewart, Ottawa Hospital Research Institute, Canada
- Philip Vanek, Gamma Biosciences, USA
- Donna Wall, The Hospital for Sick Children, Canada
- Rebecca Yu, Takeda Canada
